Clarient, Inc. (NASDAQ:CLRT)

CAPS Rating: 4 out of 5

The Company is an advanced oncology diagnostics technology and services company. It combines innovative technologies and meaningful test results to improve outcomes of patients suffering from cancer.

Recs

0
Player Avatar Fineearth (< 20) Submitted: 3/21/2009 1:08:14 PM : Outperform Start Price: $1.73 CLRT Score: +118.92

Trending in the right direction - given the investment climate they are managing cash well and able to maintain funding.

Featured Broker Partners


Advertisement